Novo Nordisk: complaint ruled outwith scope of the ABPI Code (AUTH/2696/1/14)

📅 2014 | 🖉 Dr Anzal Qurbain
πŸ“Š

Key facts

Case numberAUTH/2696/1/14
ComplainantAssociate Director of Commissioning and ex-employee
CompanyNovo Nordisk
Complaint received21 January 2014
Completed09 May 2014
Applicable Code year2012
CategoryGrievance Procedure
DecisionNo breach; outwith the scope of the Code
Case reportNo case report (outwith scope)
SanctionsNot stated

Reviewed by Dr Anzal Qurbain (FFPM) β€” ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors β€” instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough β€” coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe β€” from Β£299/yr
πŸ“‹

What happened

  • An Associate Director of Commissioning and an ex-employee made a complaint against Novo Nordisk.
  • The matter was categorised as a β€œGrievance Procedure”.
  • The PMCPA concluded the issues raised were outwith the scope of the ABPI Code of Practice.
βš–οΈ

Outcome

  • No breach (outwith the scope of the Code).
  • No case report was issued.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
Β£249/year
Annual β€” save Β£99
or
Β£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training